Want to see CH:TECN full AI Analyst Report?
TECN Stock Chart & Stats
CHF138.00
CHF1.00(0.54%)
At close: 4:00 PM EST
CHF138.00
CHF1.00(0.54%)
Day’s Range― - ―
52-Week RangeCHF110.60 - CHF177.50
Previous CloseN/A
Volume42.71K
Average Volume (3M)44.12K
Market Cap
CHF2.08B
Enterprise ValueCHF1.94B
Total Cash (Recent Filing)CHF311.37M
Total Debt (Recent Filing)CHF218.32M
Price to Earnings (P/E)―
Beta1.29
Next Earnings
Aug 11, 2026EPS Estimate
2.47Next Dividend Ex-DateN/A
Dividend Yield2.31%
Share Statistics
EPS (TTM)-8.74
Shares Outstanding12,825,883
10 Day Avg. Volume56,389
30 Day Avg. Volume44,118
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)1.41
Price to Sales (P/S)1.84
P/FCF Ratio15.85
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF173.25Price Target Upside25.54% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
EPS Forecast (FY)6.01
Revenue Forecast (FY)CHF882.43M
Bulls Say, Bears Say
Bulls Say
Strong Balance SheetLow debt-to-equity gives Tecan durable financial flexibility to fund R&D, service the installed base, and withstand cyclicality in capital-equipment demand. Conservative leverage reduces refinancing risk and supports investment or M&A optionality over the next 2–6 months and beyond.
Consistent Cash GenerationPositive operating and free cash flow, even during a net loss year, indicates resilient cash conversion from operations. This supports ongoing consumables supply, service delivery, and dividend capability while limiting reliance on external financing, helping sustain operations and strategic initiatives.
Recurring Revenue ModelA business mix of capital instruments plus recurring consumables, services, and OEM contracts creates stable, repeatable revenue. Installed-base-driven consumables and multi-year OEM relationships provide durable demand and visibility, smoothing top-line volatility and supporting long-term margin recovery.
Bears Say
Multi-year Revenue DeclineThree consecutive years of revenue contraction signal structural demand weakness or competitive share loss. Persistent top-line decline reduces scale benefits, pressures R&D and service investments, and makes margin recovery harder absent clear customer or product inflection points over the medium term.
Margin Compression And Net LossSharp operating margin erosion and a swing to a sizable net loss reflect weakened earnings quality and possible one-time or non-operating hits. Lower margins limit free cash flow upside, constrain reinvestment and dividend flexibility, and heighten sensitivity to further top-line pressure.
Weakened Equity And ROEA reduced equity base and collapsing ROE after losses diminish capital cushions and shareholder returns. This reduces headroom for strategic spending and increases vulnerability to future shocks, potentially limiting the firm's ability to finance growth internally over the coming months.
TECN FAQ
What was Tecan Group AG’s price range in the past 12 months?
Tecan Group AG lowest stock price was CHF110.60 and its highest was CHF177.50 in the past 12 months.
What is Tecan Group AG’s market cap?
Tecan Group AG’s market cap is CHF2.08B.
When is Tecan Group AG’s upcoming earnings report date?
Tecan Group AG’s upcoming earnings report date is Aug 11, 2026 which is in 41 days.
How were Tecan Group AG’s earnings last quarter?
Tecan Group AG released its earnings results on Mar 16, 2026. The company reported CHF4.26 earnings per share for the quarter, beating the consensus estimate of CHF3.39 by CHF0.87.
Is Tecan Group AG overvalued?
According to Wall Street analysts Tecan Group AG’s price is currently Undervalued.
Does Tecan Group AG pay dividends?
Tecan Group AG pays a Annually dividend of CHF3 which represents an annual dividend yield of 2.31%. See more information on Tecan Group AG dividends here
What is Tecan Group AG’s EPS estimate?
Tecan Group AG’s EPS estimate is 2.47.
How many shares outstanding does Tecan Group AG have?
Tecan Group AG has 12,825,883 shares outstanding.
What happened to Tecan Group AG’s price movement after its last earnings report?
Tecan Group AG reported an EPS of CHF4.26 in its last earnings report, beating expectations of CHF3.39. Following the earnings report the stock price went down -3.374%.
Which hedge fund is a major shareholder of Tecan Group AG?
Currently, no hedge funds are holding shares in CH:TECN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Tecan Group AG
Tecan Group AG, established in 1980 and headquartered in Männedorf, Switzerland, specializes in providing cutting-edge laboratory instruments and holistic solutions. The company caters to a broad spectrum of clients, including pharmaceutical and biotechnology corporations, university research departments, and forensic and diagnostic laboratories. Its operations are structured into two principal segments: Life Sciences Business and Partnering Business. Tecan's extensive product portfolio features automated liquid handling systems, microplate readers and washers, various consumables, reagents for Next-Generation Sequencing (NGS), immunoassays, microbodies, and specialized software. Key proprietary solutions include Tecan Laberwax for automated workflows and Resolvex, an intelligent sample preparation system applicable across diverse fields such as genomics, synthetic biology, drug discovery, analytical chemistry, cell biology, protein science, applied markets, and ELISA. Additionally, Tecan develops and manufactures crucial components—like precision pumps, valves, robotic arms, and developer software—for other laboratory instrument producers serving life science research, diagnostics, and various industrial applications. Its advanced platform-based automation solutions include Synergence, Freedom EVO, and Fluent instruments. The company's global footprint spans Switzerland, other European nations, North America, Asia, and other international markets.
TECN Company Deck
TECN Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture. While Tecan reported strong order entry and growth in the Life Sciences business, challenges in China, a decline in the Partnering Business, and external factors such as tariffs and currency impacts posed significant challenges. The company's strategic initiatives in cost reduction and innovation are positive, but the current market environment remains difficult.View all CH:TECN earnings summariesTECN Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
CHF173.25
▲(25.54% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Medacta Group SA
―
Siegfried Holding AG
―
Ypsomed Holding AG
―
SKAN Group AG
―
Medartis Holding AG
―
Options Prices
Currently, No data available
---









